Tenet Healthcare (NYSE:THC) Stock Rating Lowered by Wall Street Zen

Tenet Healthcare (NYSE:THC) was downgraded by Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Sunday.

Other analysts have also recently issued reports about the company. KeyCorp increased their price objective on Tenet Healthcare from $205.00 to $225.00 and gave the company an “overweight” rating in a research note on Wednesday, October 8th. TD Cowen lowered their price objective on Tenet Healthcare from $233.00 to $230.00 and set a “buy” rating on the stock in a report on Wednesday, January 7th. Truist Financial reiterated a “buy” rating and issued a $240.00 price target (up from $225.00) on shares of Tenet Healthcare in a research report on Monday, November 3rd. JPMorgan Chase & Co. raised their price target on Tenet Healthcare from $200.00 to $230.00 and gave the stock an “overweight” rating in a research note on Thursday, November 13th. Finally, Wells Fargo & Company decreased their target price on Tenet Healthcare from $252.00 to $229.00 and set an “overweight” rating for the company in a research report on Wednesday, January 7th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, Tenet Healthcare has an average rating of “Moderate Buy” and a consensus price target of $233.81.

Tenet Healthcare Stock Performance

Tenet Healthcare stock opened at $196.71 on Friday. The company has a market capitalization of $17.29 billion, a PE ratio of 13.48, a P/E/G ratio of 0.83 and a beta of 1.41. The company has a debt-to-equity ratio of 2.27, a quick ratio of 1.64 and a current ratio of 1.71. Tenet Healthcare has a fifty-two week low of $109.82 and a fifty-two week high of $222.82. The company has a 50 day moving average price of $201.55 and a 200-day moving average price of $190.80.

Tenet Healthcare (NYSE:THC) last released its earnings results on Tuesday, October 28th. The company reported $3.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.33 by $0.37. Tenet Healthcare had a return on equity of 25.11% and a net margin of 6.49%.The firm had revenue of $5.29 billion for the quarter, compared to the consensus estimate of $5.26 billion. During the same period in the prior year, the firm earned $2.93 EPS. The firm’s revenue was up 3.2% on a year-over-year basis. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. As a group, equities analysts forecast that Tenet Healthcare will post 12.24 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Tammy Romo sold 645 shares of the stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $205.20, for a total value of $132,354.00. Following the completion of the sale, the director directly owned 34,866 shares of the company’s stock, valued at $7,154,503.20. This represents a 1.82% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Richard W. Fisher sold 2,500 shares of the business’s stock in a transaction dated Wednesday, October 29th. The shares were sold at an average price of $208.43, for a total value of $521,075.00. Following the completion of the transaction, the director owned 8,792 shares in the company, valued at $1,832,516.56. This trade represents a 22.14% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 45,500 shares of company stock valued at $9,247,071 over the last ninety days. 0.81% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Tenet Healthcare

A number of institutional investors have recently modified their holdings of the company. Earned Wealth Advisors LLC increased its position in Tenet Healthcare by 19.9% in the 4th quarter. Earned Wealth Advisors LLC now owns 1,354 shares of the company’s stock worth $269,000 after buying an additional 225 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management acquired a new position in shares of Tenet Healthcare in the 4th quarter valued at $257,000. Burns Matteson Capital Management LLC acquired a new stake in shares of Tenet Healthcare during the 4th quarter valued at about $757,000. Foster & Motley Inc. lifted its stake in Tenet Healthcare by 8.9% during the fourth quarter. Foster & Motley Inc. now owns 9,215 shares of the company’s stock worth $1,831,000 after purchasing an additional 756 shares during the period. Finally, Northwest Wealth Management LLC bought a new stake in shares of Tenet Healthcare in the 4th quarter valued at approximately $200,000. Institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.